So Jung Lee

Title: So Jung Lee: Innovator in Influenza Virus Neutralization

Introduction

So Jung Lee is a prominent inventor based in Incheon, South Korea. She has made significant contributions to the field of virology, particularly in the development of compositions that target influenza A viruses. Her innovative work is crucial for advancing treatments and preventive measures against influenza.

Latest Patents

So Jung Lee holds a patent for a composition comprising at least two influenza A virus-neutralizing binding molecules. This invention provides a method that includes a first binding molecule capable of neutralizing specific influenza A virus subtypes, such as H1, H2, H5, and H9. Additionally, it features a second binding molecule that neutralizes other subtypes, including H1, H3, H5, H7, and H9. The mixed composition effectively neutralizes multiple influenza subtypes from both phylogenetic groups, making it a valuable tool for preventing and treating influenza virus-related diseases. She has 1 patent to her name.

Career Highlights

So Jung Lee is currently associated with Celltrion Inc., a leading biopharmaceutical company. Her work at Celltrion focuses on developing innovative solutions to combat viral infections, particularly influenza. Her research has the potential to impact public health significantly.

Collaborations

So Jung Lee collaborates with notable colleagues, including Seung Suh Hong and Shin Jae Chang. These partnerships enhance the research and development efforts at Celltrion Inc., fostering innovation in the field of virology.

Conclusion

So Jung Lee's contributions to influenza virus research exemplify the importance of innovation in healthcare. Her patented compositions represent a significant advancement in the fight against viral infections.